21 October 2022 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Atherosclerotic cardiovascular disease is a major cause of human disability and mortality. Our previous study demonstrated the safety and efficacy of sonodynamic therapy (SDT) on atherosclerotic plaques. However, traditional single-element therapeutic transducer has single acoustic field, and positioning therapeutic and imaging transducers in the same position is difficult during ultrasound imaging-guided SDT. Continuously changing the position of transducers to intervene lesions in different positions is required, increasing the difficulty of treatment. Thus, SDT device with precise theranostics is required. Therefore, we designed and fabricated a ’concentric ultrasound transducer for theranostics’ (CUST-T), comprising a central 8 MHz linear array transducer for ultrasound imaging, and a peripheral 1 MHz hollow two-dimensional planar array transducer for generating phased-array focused ultrasound (PAFUS). The CUST-T exhibited high imaging resolution at a distance of up to 20 mm from the transducer and could generate personalized complex PAFUS acoustic field to match various lesions. In vitro biomedical results showed that, PAFUS-SDT induced RAW264.7-derived foam cell apoptosis leading to a targeting field apoptotic rate 4.36 to 6.24-times that of the non-targeting field and the significant apoptotic region was consistent with PAFUS acoustic field. In vivo , PAFUS-SDT guided by ultrasound imaging significantly increased the lumen area (P < 0.05) and collagen level (P < 0.01), whereas the wall thickness (P < 0.05) and lipid content (P < 0.01) of rabbit femoral artery were reduced. In conclusion, CUST-T provided image guidance sufficient for accurate SDT for atherosclerotic plaques in peripheral arteries and could be applied in clinical practice.
12 August 2025 in Research Square
JBJoan Marie Javillo Baguio
Joan Marie Javillo Baguio
BABehzad Nasiri Ahmadabadi
+19
Chronic obstructive pulmonary disease (COPD) is a leading cause of death and morbidity, and the inability of current treatments to repair lung damage creates an urgent need for novel regenerative therapies. Human umbilical cord blood small extracellular vesicles (hUCB-sEV) are enriched with regenerative factors from multiple progenitor cells, demonstrating great potential for COPD treatment. Herein, we integrated patient-derived COPD airway organoids with InSMAR-chip system to assess the efficiency and mechanism of hUCB-sEV in a high-throughput manner. Our COPD organoids recapitulated disease characteristics following severity gradient and our hUCB-sEV isolation pipeline yielded sEV with high purity, homogeneity, consistency and wound-healing related protein profile. These hUCB-sEVs promoted differentiation and reduced collagen and Notch gene expression and restored intercellular communication on COPD organoids without detectable off-target effect. Collectively, this study illustrates the therapeutic potential of hUCB-sEV for COPD, laying solid foundation for their clinical translation.